Key result
The AGTR1 rs3772616 TT genotype significantly decreased the risk of primary aldosteronism compared with the CC homozygote (adjusted OR 0.13; 95% CI 0.03-0.59; p=0.008).
Why the study?
Are polymorphisms in AGTR1 and AGTR2 genes associated with primary aldosteronism in the Chinese Han population?
Case-Control (n=390)
Are polymorphisms in AGTR1 and AGTR2 genes associated with primary aldosteronism in the Chinese Han population?
The AGTR1 rs3772616 polymorphism may serve as a hereditary marker for primary aldosteronism in the Chinese Han population.
May support AGTR1 rs3772616 as hereditary marker in Chinese Han; leaves open prospective validation before clinical adoption.
HYPOTHESIS: Polymorphisms in angiotensin II type-1/2 receptor genes (AGTR1/AGTR2) may be involved in the pathogenesis of primary aldosteronism. The present study aims to reveal some loci susceptible to the disease on the genes in a group of Chinese Han nationality. MATERIALS AND METHODS: A case-control study was conducted in 202 patients and 188 controls. Ten tagging SNPs on AGTR1/AGTR2 were genotyped for all subjects via the method of multiplex PCR-ligase detection reaction. Statistical analysis was performed with chi-square test and logistic regression analysis. RESULTS: rs3772616 on the AGTR1 gene was a factor for susceptibility to primary aldosteronism (p<0.001), and the TT genotype significantly decreased the risk of primary aldosteronism compared with the CC homozygote (p=0.008, adjusted OR=0.13; 95%CI: 0.03-0.59). The rs3772616 polymorphism was associated with primary aldosteronism under the additive and dominant models. The female carriers of the G allele in rs5193 showed a significant difference compared with the T allele. CONCLUSIONS: The AGTR1 rs3772616 polymorphism can be considered as a hereditary marker for primary aldosteronism, and in the Chinese Han population the rs5193 G allele seems to predispose to it only in women.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2014) conducted a case-control in Primary aldosteronism (n=390). AGTR1 rs3772616 TT genotype vs. CC homozygote was evaluated on Risk of primary aldosteronism (OR 0.13, 95% CI 0.03-0.59, p=0.008). The AGTR1 rs3772616 TT genotype significantly decreased the risk of primary aldosteronism compared with the CC homozygote (adjusted OR 0.13; 95% CI 0.03-0.59; p=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: